Yishi Lu

ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma

Wenbin Huang, Kunling Chen, Yishi Lu et al. · Neoplasia · 2021 · 142 citations · Full text

Medicine, Oncology, Pharmacology +17

CRIP1 suppresses BBOX1‐mediated carnitine metabolism to promote stemness in hepatocellular carcinoma

Jing Wang, Yan Zhou, Donghui Zhang et al. · The EMBO Journal · 2022 · 60 citations · Full text

Medicine, Molecular Biology, Oncology +13

Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma

Yuan Cheng, Lei Luo, Juqiang Zhang et al. · Journal of Gastrointestinal Surgery · 2019 · 52 citations

Medicine, Cancer Biology, Oncology +16

MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity

Erbo Liang, Yishi Lu, Yanqiang Shi et al. · Oncogene · 2020 · 43 citations

Medicine, Molecular Biology, Oncology +8

Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1

Yujun Tang, Yishi Lu, Yuan Chen et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17